For lung cancer, early diagnosis and staging is crucial to survival. However, the length of the lung cancer pathway differs between regions in the UK due to a variety of reasons. As explained here by Robert Rintoul, PhD, FRCP, of the Cancer Research UK Cambridge Institute, Cambridge, UK, the National Optimal Lung Cancer Pathway (NOLCP) was developed to combat this, giving patients across the UK access to rapid diagnosis, staging and treatment. Dr Rintoul discusses how this can highlight the different aspects that can be limiting the speed of a center through the care pathway. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.
Rapid access to lung cancer care in the UK: the NOLCP
